Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc |
Journal website http://www.jofem.org |
Original Article
Volume 6, Number 3, June 2016, pages 80-89
Hypovitaminosis D Is Associated With Visceral Adiposity, High Levels of Low-Density Lipoprotein and Triglycerides in Alternating Shift Workers
Tables
Variables | 25(OH)D < 30 ng/mL (75 nmol/L) | 25(OH)D ≥ 30 ng/mL (75 nmol/L) | Total | n | Odds ratio (95% CI) | P value* |
---|---|---|---|---|---|---|
aSystolic blood pressure ≥ 140 mm Hg and diastolic blood pressure ≥ 90 mm Hg or use of antihypertensive (VI Diretrizes Brasileira de Hipertensao, 2010). bOne or more ATPIII criteria: total cholesterol ≥ 200 mg/dL, LDL-c ≥ 130 mg/dL, HDL-c < 40 mg/dL, TG ≥ 150 mg/dL, VLDL-c ≥ 30 mg/dL. | ||||||
Age (years), mean ± SD | 36.7 ± 7.5 | 34.7 ± 6.4 | 36.1 ± 7.3 | 391 | - | 0.016 |
Skin color | % | 0.835 | ||||
White | 100 (35.1) | 36 (34) | 34.8 | 136 | 1.0 | |
Non-white | 185 (64.9) | 70 (66) | 65.2 | 255 | 0.95 (0.59 - 1.52) | |
Total | 391 | |||||
Education | % | 0.175 | ||||
≤ 8 years | 32 (11.2) | 7 (6.6) | 10.0 | 39 | 1.0 | |
> 8 years | 253 (88.8) | 99 (93.4) | 90.0 | 352 | 0.56 (0.24 - 1.31) | |
Total | 391 | |||||
Time spent in shift work | % | 0.427 | ||||
≤ 5 years | 135 (47.4) | 55 (51.9) | 48.6 | 190 | 1.0 | |
> 5 years | 150 (52.6) | 51 (48.1) | 51.4 | 201 | 1.19 (0.76 - 1.87) | |
Total | 391 | |||||
Seasonality | % | < 0.0001 | ||||
Spring | 221 (77.5) | 61 (57.5) | 72.1 | 282 | 1.0 | |
Summer | 64 (22.5) | 45 (42.5) | 27.9 | 108 | 0.72 (0.68 - 0.77) | |
Total | 391 | |||||
Smoking | % | 0.183 | ||||
No | 220 (82.1) | 87 (87.9) | 83.7 | 307 | 1.0 | |
Yes | 48 (17.9) | 12 (12.1) | 16.3 | 60 | 1.58 (0.80 - 3.12) | |
Total | 367 | |||||
Alcohol consumption | % | 0.135 | ||||
Low risk | 246 (86.3) | 85 (80.2) | 84.7 | 331 | 1.0 | |
Risk | 39 (13.7) | 21 (19.8) | 15.3 | 60 | 0.64 (0.35 - 1.15) | |
Total | 391 | |||||
Physical activity | % | 0.103 | ||||
≥ 3 days/week | 42 (14.7) | 9 (8.5) | 87.0 | 340 | 1.0 | |
< 3 days/week | 243 (85.3) | 97 (91.5) | 13.0 | 51 | 1.86 (0.87 - 3.97) | |
Total | 391 | |||||
Hypertensiona | % | 0.057 | ||||
No | 90 (33.6) | 23 (23.2) | 69.2 | 113 | 1.0 | |
Yes | 178 (66.4) | 76 (76.8) | 30.8 | 254 | 0.6 (0.35 - 1.01) | |
Total | 367 | |||||
Dyslipidemiab | % | < 0.0001 | ||||
No | 58 (20.4) | 43 (40.6) | 25.8 | 101 | 1.0 | |
Yes | 227 (79.6) | 63 (59.4) | 74.2 | 290 | 2.7 (1.6 - 4.3) | |
Total | 391 |
Variables | 25(OH)D < 30 ng/mL (75 nmol/L) | 25(OH)D ≥ 30 ng/mL (75 nmol/L) | Mean (SD) | n | Odds ratio (95% CI) | P value* |
---|---|---|---|---|---|---|
BMI: body mass index; WC: waist circumference; NC: neck circumference; WHR: waist-hip ratio; WHER: waist-height ratio; TC: total cholesterol; HDL-c: low-density lipoprotein cholesterol; LDL-c: high-density lipoprotein cholesterol; TG: triglycerides; VLDL-c: very low-density lipoprotein cholesterol; PTH: parathyroid hormone; CRP: C-reactive protein; SBP: systolic blood pressure; DBP: diastolic blood pressure. **Amounts expressed in the logarithmic form. *P value for Pearson’s Chi-square < 0.05 was considered significant. | ||||||
BMI (kg/m2) | 26.6 (3.7) | 0.015 | ||||
< 25 | 83 (30.9) | 44 (44.4) | 127 | 1.0 | ||
≥ 25 | 186 (69.1) | 55 (55.6) | 241 | 1.8 (1.11 - 2.87) | ||
Total | 368 | |||||
WC (cm) | 91.2 (11.2) | 0.025 | ||||
< 90 | 101 (37.5) | 50 (50.5) | 151 | 1.0 | ||
≥ 90 | 168 (62.5) | 49 (49.5) | 217 | 1.69 (1.06 - 2.7) | ||
Total | 368 | |||||
NC (cm) | 39.3 (3.3) | 0.008 | ||||
< 39.5 | 129 (48) | 63 (63.6) | 192 | 1.0 | ||
≥ 39.5 | 140 (52) | 36 (36.4) | 176 | 1.9 (1.2 - 3.0) | ||
Total | 368 | |||||
WHR | 0.9 (0.8) | 0.017 | ||||
< 0.90 | 128 (47.6) | 61 (61.6) | 189 | 1.0 | ||
≥ 0.90 | 141 (52.4) | 38 (38.4) | 179 | 1.76 (1.1 - 2.8) | ||
Total | 368 | |||||
WHER | 0.52(0.06) | 0.000 | ||||
< 0.50 | 63 (23.6) | 42 (42.4) | 105 | 1.0 | ||
≥ 0.50 | 204 (76.4) | 57 (57.6) | 261 | 2.38 (1.5 - 3.9) | ||
Total | 366 | |||||
Visceral fat area (cm3) | 8.3 (5.8) | 0.002 | ||||
1 - 10 | 196 (73.1) | 87 (88.8) | 283 | 1.0 | ||
11 - 20 | 72 (26.9) | 11 (11.2) | 83 | 2.9 (1.5 - 5.7) | ||
Total | 366 | |||||
SBP (mm Hg) | 133.0 (12.8) | 0.06 | ||||
< 140 | 179 (66.5) | 76 (76.8) | 255 | 1.0 | ||
≥ 140 | 90 (33.5) | 23 (23.2) | 113 | 1.66 (1.0 - 2.8) | ||
Total | 368 | |||||
DBP (mm Hg) | 82.9 (8.9) | 0.168 | ||||
< 90 | 207 (77.2) | 83 (83.8) | 290 | 1.0 | ||
≥ 90 | 61 (22.8) | 16 (16.2) | 77 | 1.52 (0.83 - 2.8) | ||
Total | 367 | |||||
PTH (pg/mL) | 31.4 (11.1) | 0.217 | ||||
< 65 | 275 (98.6) | 105 (100) | 380 | 1.0 | ||
≥ 65 | 4 (1.4) | 0 (0) | 4 | 0.72 (0.7 - 0.8) | ||
Total | 384 | |||||
TC (mg/dL) | 195.3 (43.1) | 0.05 | ||||
< 240 | 239 (83.9) | 97 (91.5) | 336 | 1.0 | ||
≥ 240 | 46 (16.1) | 9 (8.5) | 55 | 2.07 (1.0 - 4.4) | ||
Total | 391 | |||||
HDL-c (mg/dL) | 55.4 (17.1) | 0.656 | ||||
≥ 40 | 231 (81.1) | 88 (83.0) | 319 | 1.0 | ||
< 40 | 54 (18.9) | 18 (17.0) | 72 | 1.14 (0.6 - 2.0) | ||
Total | 391 | |||||
LDL-c (mg/dL) | 109.8 (36.5) | 0.003 | ||||
< 160 | 241 (86.7) | 101 (97.1) | 342 | 1.0 | ||
≥ 160 | 37 (13.3) | 3 (2.9) | 40 | 5.2 (1.5 - 17.1) | ||
Total | 382 | |||||
TG (mg/dL) | 155.8 (84.8) | 0.000 | ||||
< 150 | 140 (49.1) | 75 (70.8) | 215 | 1.0 | ||
≥ 150 | 145 (50.9) | 31 (29.2) | 176 | 2.5 (1.5 - 4.0) | ||
Total | 391 | |||||
VLDL-c (mg/dL) | 30.0 (14.0) | 0.000 | ||||
< 30 | 140 (50) | 75 (72.1) | 215 | 1.0 | ||
≥ 30 | 140 (50) | 29 (27.9) | 169 | 2.6 (1.6 - 4.2) | ||
Total | 384 | |||||
Fasting glucose (mg/dL) | 88.3 (16.6) | 0.025 | ||||
< 100 | 245 (88.8) | 101 (96.2) | 346 | 1.0 | ||
≥ 100 | 31 (11.2) | 4 (3.8) | 35 | 3.2 (1.1 - 9.3) | ||
Total | 381 | |||||
Adiponectin (pg/mL)** | 6.5 (0.5) | 0.895 | ||||
< 6.77 | 142 (75.9) | 51 (75) | 193 | 1.0 | ||
≥ 6.77 | 45 (24.1) | 17 (25) | 62 | 0.95 (0.5 - 1.8) | ||
Total | 255 | |||||
Fasting insulin (pg/mL)** | 2.45 (0.26) | 0.110 | ||||
< 2.6 | 56 (82.4) | 135 (72.6) | 191 | 1.0 | ||
≥ 2.6 | 12 (17.6) | 51 (27.4) | 63 | 1.7 (0.8 - 3.5) | ||
Total | 254 | |||||
CRP (mg/L) | 8.7 (10) | 0.820 | ||||
< 3 | 20 (29.4) | 52 (28.0) | 72 | 1.0 | ||
≥ 3 | 48 (70.6) | 134 (72) | 182 | 1.1 (0.6 - 2.0) | ||
Total | 254 |
Variables | Quartile 1 (0 - 19.9 ng/mL) (0 - 49.9 nmol/L) | Quartile 2 (20 - 24.6 ng/mL) (50 - 61.1 nmol/L) | Quartile 3 (24.7 - 29.7 ng/mL) (61.2 - 74.2 nmol/L) | Quartile 4 (29.8 - 60 ng/mL) (74.3 - 150 nmol/L) | P value* |
---|---|---|---|---|---|
*Amount expressed in the logarithmic form one-way ANOVA TG. TC: total cholesterol; HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density lipoprotein cholesterol; TG: triglycerides; VLDL-c: very low-density lipoprotein cholesterol; BMI: body mass index; VFA: visceral fat area; PTH: parathyroid hormone; FG: fasting glucose; FI: fasting insulin; ADP: adiponectin; SBP: systolic blood pressure; DBP: diastolic blood pressure. *P value for the ANOVA < 0.05 was considered significant. a,b,cEqual letters indicate similar means Tukey post-test. | |||||
TG (mg/dL) | 191.1 ± 90.3a | 169.4 ± 89.9a | 134.8 ± 63.8b | 132.5 ± 79.8b | < 0.001 |
TC (mg/dL) | 199.4 ± 47.9a, b | 202.4 ± 41.3b | 197.0 ± 43.6a, b | 183.7 ± 38.1a | 0.010 |
HDL-c (mg/dL) | 52.2 ± 17.2a | 54.6 ± 15.5a | 56.6 ± 18.0a | 57.8 ± 17.6a | 0.109 |
LDL-c (mg/dL) | 111.0 ± 37.2a, b | 115. 7 ± 37.0a | 113.7 ± 39.5a | 100.0 ± 30.7b | 0.011 |
VLDL-c (mg/dL) | 36.8 ± 15.5a | 32.1 ± 12.4a | 26.3 ± 11.2b | 25.3 ± 13.7b | < 0.001 |
BMI (kg/m2) | 27.5 ± 2.8a | 28.0 ± 4.2a | 25.5 ± 3.5b | 25.5 ± 3.3b | < 0.001 |
VFA (cm3) | 9.2 ± 3.0a | 9.1 ± 3.6a | 7.1 ± 2.8b | 7.8 ± 9.7b | < 0.001 |
PTH (pg/mL) | 35.4 ± 13.5a | 31.3 ± 10.6b | 29.6 ± 9.1b | 29.9 ± 10.3b | 0.001 |
FG (mg/dL) | 93.2 ± 26.6a | 89.4 ± 12.7a, b | 86.6 ± 14.0b | 85.0 ± 8.0b | 0.004 |
FI (pg/mL)* | 2.5 ± 0.2a | 2.5 ± 0.3a | 2.4 ± 0.3a | 2.4 ± 0.3a | 0.017 |
ADP (pg/mL)* | 6.6 ± 0.3a | 6.5 ± 0.3a | 6.5 ± 0.6a | 6.6 ± 0.4a | 0.288 |
SBP (mm Hg) | 135.9 ± 12.6a | 134.0 ± 12.4a, b | 132.0 ± 12.9a, b | 130.3 ± 12.8b | 0.020 |
DBP (mm Hg) | 84.9 ± 9.2a | 84.2 ± 9.4a | 81.7 ± 7.6a, b | 80.8 ± 8.8b | 0.003 |
Variables | Crude odds ratio (95% CI) | P value | Adjusted odds ratio* (95% CI) | P value |
---|---|---|---|---|
CI: confidence interval. *Adjusting for age and seasonality. | ||||
Visceral fat area (cm3) | ||||
11 - 20 | 2.9 (1.5 - 5.7) | 0.002 | 2.4 (1.1 - 5.2) | 0.037 |
LDL-cholesterol level (mg/dL) | ||||
≥ 160 | 5.2 (1.5 - 17.1) | 0.003 | 5.9 (1.3 - 25.7) | 0.018 |
Triglycerides level (mg/dL) | ||||
≥ 150 | 2.5 (1.5 - 4.0) | 0.000 | 2.3 (1.3 - 4.0) | 0.003 |
Insufficient | Sufficient | Crude odds ratio (95% CI) | P value | Adjusted odds ratio* (95%CI) | P value | ||
---|---|---|---|---|---|---|---|
CI: confidence interval; TG: triglycerides; VFA: visceral fat area; LDL-c: high density lipoprotein. *Adjusting for age and seasonality. | |||||||
TG | VFA | ||||||
No | No | 141 (66.8) | 70 (33.2) | 1.0 | - | 1.0 | |
No | Yes | 27 (77.1) | 8 (2.9) | 1.7 (0.7 - 3.9) | 0.22 | 2.0 (0.80 - 4.89) | 0.14 |
Yes | No | 105 (80.8) | 25 (19.2) | 2.1 (1.2 - 3.5) | 0.005 | 2.2 (1.23 - 3.83) | 0.008 |
Yes | Yes | 50 (94.3) | 3 (5.7) | 8.2 (2.5 - 27.5) | < 0.001 | 8.2 (2.38 - 28.51) | 0.001 |
LDL-c | TG | ||||||
No | No | 164 (67.5) | 79 (32.5) | 1.0 | - | 1.0 | |
No | Yes | 130 (81.3) | 30 (18.7) | 2.1 (1.3 - 3.4) | 0.002 | 2.1 (1.2 - 3.5) | 0.007 |
Yes | No | 16 (88.9) | 2 (16.1) | 3.9 (1.9 - 17) | 0.058 | 3.5 (0.7 - 16.1) | 0.107 |
Yes | Yes | 24 (96.0) | 1 (4.0) | 11.6 (1.5 - 87.0) | 0.003 | 11.1 (1.4 - 84.2) | 0.02 |